BE616779A - Method of stabilizing therapeutically useful plasmin solutions - Google Patents

Method of stabilizing therapeutically useful plasmin solutions

Info

Publication number
BE616779A
BE616779A BE616779A BE616779A BE616779A BE 616779 A BE616779 A BE 616779A BE 616779 A BE616779 A BE 616779A BE 616779 A BE616779 A BE 616779A BE 616779 A BE616779 A BE 616779A
Authority
BE
Belgium
Prior art keywords
stabilizing
therapeutically useful
plasmin
solutions
plasmin solutions
Prior art date
Application number
BE616779A
Other languages
French (fr)
Inventor
Villy Johannes Jensen
Original Assignee
Novo Terapeutisk Labor As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Terapeutisk Labor As filed Critical Novo Terapeutisk Labor As
Publication of BE616779A publication Critical patent/BE616779A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BE616779A 1961-04-25 1962-04-24 Method of stabilizing therapeutically useful plasmin solutions BE616779A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK169161AA DK98833C (en) 1961-04-25 1961-04-25 Method for stabilizing therapeutically useful plasmin solutions.

Publications (1)

Publication Number Publication Date
BE616779A true BE616779A (en) 1962-10-24

Family

ID=8107240

Family Applications (1)

Application Number Title Priority Date Filing Date
BE616779A BE616779A (en) 1961-04-25 1962-04-24 Method of stabilizing therapeutically useful plasmin solutions

Country Status (9)

Country Link
BE (1) BE616779A (en)
CH (1) CH456848A (en)
DK (1) DK98833C (en)
FI (1) FI43764B (en)
FR (1) FR2140M (en)
GB (1) GB985498A (en)
NL (1) NL147634B (en)
NO (1) NO123024B (en)
SE (1) SE327779B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2750159C3 (en) * 1977-11-09 1980-05-22 Lentia Gmbh, Chem. U. Pharm. Erzeugnisse - Industriebedarf, 8000 Muenchen Infusion solution for the treatment of hepatic encephalopathy and a process for the manufacture thereof
JPH0672105B2 (en) * 1985-10-02 1994-09-14 持田製薬株式会社 Thrombolytic agent and manufacturing method thereof
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
US7544500B2 (en) 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6355243B1 (en) † 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
EP1545588A4 (en) * 2002-07-23 2007-12-05 Ludwig Inst Cancer Res Methods and compositions for activating or inhibiting vegf-d and vegf-c
GB0228409D0 (en) 2002-12-06 2003-01-08 Thromb X Nv Pharmacological vitreolysis
US20060257391A1 (en) * 2005-05-11 2006-11-16 Bausch & Lomb Incorporated Non-surgical method for preventing or reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions
BRPI0913397B8 (en) 2008-06-04 2021-05-25 Grifols Therapeutics Inc method for preparing plasmin
JP5789521B2 (en) 2009-03-03 2015-10-07 グリフオルス・セラピユーテイクス・インコーポレーテツドＧｒｉｆｏｌｓ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． Compositions, methods and kits for producing plasminogen; and plasmin produced therefrom
CN106167797B (en) * 2016-07-28 2019-04-09 国药集团武汉血液制品有限公司 The lyophilized preparation and preparation method thereof of human fibrin dissolution proenzyme

Also Published As

Publication number Publication date
SE327779B (en) 1970-08-31
CH456848A (en) 1968-05-31
FR2140M (en) 1963-11-12
GB985498A (en) 1965-03-10
NO123024B (en) 1971-09-20
DK98833C (en) 1964-05-25
FI43764B (en) 1971-03-01
NL147634B (en) 1975-11-17

Similar Documents

Publication Publication Date Title
FR1196375A (en) Method of stabilizing an arc
CH404192A (en) Method for stabilizing rubber compositions
BE616779A (en) Method of stabilizing therapeutically useful plasmin solutions
FR1201217A (en) Polyolefin stabilization process
FR85965E (en) Process for stabilizing polyolefins and new stabilizers
CH411573A (en) Diazotype process
FR1303273A (en) New expansion process
FR1328254A (en) Polyacrylic nitrile stabilization process
BE614985A (en) Polyacetal stabilization process
FR1300781A (en) Peracid stabilization process
FR1299862A (en) Polyolefin stabilization process
FR1403608A (en) Method for stabilizing cultures of pathogens
FR1284136A (en) Process for stabilizing phosphoryl-tri
FR1334972A (en) Method for stabilizing plasmin solutions
FR1294410A (en) Polyolefin stabilization process
FR1286118A (en) Process for stabilizing polyoxymethylenes
FR1319197A (en) Polyoxymethylene stabilization process
FR1329303A (en) Polyoxymethylene stabilization process
FR1321005A (en) Polyacetal stabilization process
FR1339161A (en) Polyacetal stabilization process
FR1361673A (en) Polyacetal stabilization process
FR1324494A (en) Advanced process for stabilizing polyesters
FR1284090A (en) Construction process
FR1299176A (en) Polyacetal stabilization process
FR1296904A (en) Polyacetal stabilization process